Michael Callahan's career began in USAID and in the bioweapons labs of the former Soviet Union, advancing the agenda of the global bioweapons and pharmaceutical cartels. He would take what he learned there to execute a massive expansion of DARPA's biodefense portfolio and today finds himself squarely in the center of the origins of the coronavirus pandemic.
July 31, 2020
Techno-Tyranny: How The US National Security State Is Using Coronavirus To Fulfill An Orwellian Vision
Last year, a government commission called for the US to adopt an AI-driven mass surveillance system far beyond that used in any other country in order to ensure American hegemony in artificial intelligence. Now, many of the “obstacles” they had cited as preventing its implementation are rapidly being removed under the guise of combating the coronavirus crisis.
May 4, 2020
A Killer Enterprise: How One of Big Pharma’s Most Corrupt Companies Plans to Corner the Covid-19 Cure Market
One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 anthrax attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.
April 9, 2020
Though often discussed in relation to nuclear war or a similarly chaotic scenario, "Continuity of Government" plans can be triggered even by popular, nonviolent opposition to an unpopular war abroad. It exists solely to keep the current system in place, regardless of the cost.
March 23, 2020
As Coronavirus panic grips the world, concern over government overreach is growing given the involvement of US intelligence agencies in classified meetings for planning the U.S.’ coronavirus response.
March 20, 2020
Bats, Gene Editing and Bioweapons: Recent DARPA Experiments Raise Concerns Amid Coronavirus Outbreak
DARPA recently spent millions on research involving bats and coronaviruses, as well as gene editing “bioweapons” prior to the recent coronavirus outbreak. Now, “strategic allies” of the agency have been chosen to develop a genetic material-based vaccine to halt the potential epidemic.
March 20, 2020